JP2007512237A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007512237A5 JP2007512237A5 JP2006536948A JP2006536948A JP2007512237A5 JP 2007512237 A5 JP2007512237 A5 JP 2007512237A5 JP 2006536948 A JP2006536948 A JP 2006536948A JP 2006536948 A JP2006536948 A JP 2006536948A JP 2007512237 A5 JP2007512237 A5 JP 2007512237A5
- Authority
- JP
- Japan
- Prior art keywords
- ibandronate sodium
- ray
- crystalline form
- reflection
- sodium crystalline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60402604P | 2004-08-23 | 2004-08-23 | |
| US69086705P | 2005-06-16 | 2005-06-16 | |
| PCT/US2005/030500 WO2006024024A2 (en) | 2004-08-23 | 2005-08-23 | Solid and crystalline ibandronate sodium and processes for preparation thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007512237A JP2007512237A (ja) | 2007-05-17 |
| JP2007512237A5 true JP2007512237A5 (enExample) | 2008-02-14 |
| JP4559431B2 JP4559431B2 (ja) | 2010-10-06 |
Family
ID=35968334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006536948A Expired - Lifetime JP4559431B2 (ja) | 2004-08-23 | 2005-08-23 | 固体及び結晶イバンドロネートナトリウム及びその調製方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7563918B2 (enExample) |
| EP (2) | EP1713489B1 (enExample) |
| JP (1) | JP4559431B2 (enExample) |
| KR (2) | KR20070043043A (enExample) |
| CN (1) | CN101022812A (enExample) |
| AT (2) | ATE495747T1 (enExample) |
| CA (1) | CA2576659A1 (enExample) |
| DE (2) | DE202005021414U1 (enExample) |
| ES (1) | ES2358269T3 (enExample) |
| IL (1) | IL181298A (enExample) |
| PT (2) | PT1713489E (enExample) |
| WO (1) | WO2006024024A2 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1663182B2 (en) | 2003-09-12 | 2019-11-20 | Amgen Inc. | RAPID DISSOLUTION FORMULATION OF CINACALCET HCl |
| WO2006081962A1 (en) * | 2005-02-01 | 2006-08-10 | F.Hoffmann-La Roche Ag | Ibandronate polymorph b |
| HUE042316T2 (hu) * | 2005-02-01 | 2019-06-28 | Atnahs Pharma Uk Ltd | Az Ibandronát A polimorf orvosi alkalmazása |
| WO2007074475A2 (en) * | 2005-12-27 | 2007-07-05 | Natco Pharma Limited | Novel polymorphic forms of ibandronate |
| WO2008014510A2 (en) * | 2006-07-28 | 2008-01-31 | Dr. Reddy's Laboratories Limited | Crystalline form a of ibandronic acid and process for the preparation |
| US20090012047A1 (en) * | 2006-11-16 | 2009-01-08 | Eran Turgeman | Crystalline forms of ibandronate sodium |
| CA2570949A1 (en) | 2006-12-12 | 2008-06-12 | Apotex Pharmachem Inc. | Ibandronate sodium propylene glycol solvate and processes for the preparation thereof |
| AU2008238058B2 (en) | 2007-04-11 | 2010-12-02 | F. Hoffmann-La Roche Ag | Multi step synthesis of ibandronate |
| EP2316841A1 (en) | 2007-04-19 | 2011-05-04 | Dr. Reddy's Laboratories Limited | Ibandronate sodium polymorphs |
| WO2009020483A1 (en) * | 2007-08-09 | 2009-02-12 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of ibandronate sodium |
| EP2128166A1 (en) | 2008-05-20 | 2009-12-02 | Chemo Ibérica, S.A. | Polymorphic forms of Ibandronate sodium and processes for preparation thereof |
| WO2009053445A2 (en) * | 2007-10-26 | 2009-04-30 | Chemo Ibérica, S.A. | Polymorphic forms of ibandronate sodium and processes for preparation thereof |
| WO2009061336A1 (en) * | 2007-11-05 | 2009-05-14 | Teva Pharmaceutical Industries Ltd. | Amorphous and crystalline forms of ibandronate disodium |
| EP2180003A1 (en) | 2008-10-21 | 2010-04-28 | Zentiva, k.s. | Preparation of ibandronate trisodium |
| HUE050287T2 (hu) | 2009-02-13 | 2020-11-30 | Boehringer Ingelheim Int | SGLT2-inhibitort, DPP-IV-inhibitort és adott esetben egy további antidiabetikus hatóanyagot tartalmazó gyógyászati készítmény és alkalmazásai |
| US9192316B2 (en) | 2009-05-15 | 2015-11-24 | Nox Medical | Systems and methods using flexible capacitive electrodes for measuring biosignals |
| WO2011016738A1 (en) | 2009-08-05 | 2011-02-10 | Zaklady Farmaceutyczne Polpharma Sa | A process for the synthesis of 1-hydroxy-3-(n-methylpentylamino) propylidene bisphosphonic acid monosodium salt, monohydrate |
| RS54123B1 (sr) | 2010-01-27 | 2015-12-31 | Viiv Healthcare Company | Terapeutska kombinacija koja sadrži dolutegravir, abacavir i lamivudine |
| US9059532B2 (en) | 2010-06-25 | 2015-06-16 | Nox Medical | Biometric belt connector |
| CN103957931B (zh) | 2010-09-03 | 2017-10-24 | 瓦尔内瓦奥地利有限责任公司 | 艰难梭状芽胞杆菌毒素a和毒素b蛋白的分离多肽及其用途 |
| AR085689A1 (es) | 2011-03-07 | 2013-10-23 | Boehringer Ingelheim Int | Composiciones farmaceuticas de metformina, linagliptina y un inhibidor de sglt-2 |
| WO2013179305A1 (en) * | 2012-06-01 | 2013-12-05 | Hetero Research Foundation | Ibandronate sodium solid dispersion |
| WO2014170909A2 (en) | 2013-04-01 | 2014-10-23 | Hetero Research Foundation | Process for pomalidomide |
| US10588550B2 (en) | 2013-11-06 | 2020-03-17 | Nox Medical | Method, apparatus, and system for measuring respiratory effort |
| KR102495018B1 (ko) | 2013-11-15 | 2023-02-06 | 아케비아 테라퓨틱스 인코포레이티드 | ｛[5-(3-클로로페닐)-3-하이드록시피리딘-2-카보닐]아미노｝아세트산의 고체형, 이의 조성물 및 용도 |
| EP3500155B1 (en) | 2016-08-19 | 2024-10-02 | Nox Medical | Method, system, and computer program for measuring respiratory effort of a subject |
| US11896386B2 (en) | 2017-06-02 | 2024-02-13 | Nox Medical Ehf | Coherence-based method, apparatus, and system for identifying corresponding signals of a physiological study |
| EP3678543A1 (en) | 2017-09-08 | 2020-07-15 | Nox Medical | System and method for non-invasively determining an internal component of respiratory effort |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3623397A1 (de) * | 1986-07-11 | 1988-01-14 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| JP2639721B2 (ja) | 1988-12-27 | 1997-08-13 | 富士重工業株式会社 | 内燃機関の燃焼室 |
| US5652227A (en) * | 1995-01-30 | 1997-07-29 | Teronen; Olli Pekka | Inhibition of the degradation of connective tissue matrix protein components in mammals |
| DE19637890A1 (de) * | 1996-09-17 | 1998-03-19 | Max Planck Gesellschaft | Biphosphonat-Liposomen |
| DE19828450A1 (de) * | 1998-06-26 | 1999-12-30 | Hassan Jomaa | Bisphosphonsäuren und deren Derivate enthaltende Arzneimittel zur Prophylaxe und zur Behandlung von Autoimmunkrankheiten sowie von Allergien |
| EP0998933A1 (de) * | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation |
| EP0998932A1 (de) * | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung |
| PT1178810E (pt) * | 1999-05-21 | 2005-08-31 | Novartis Ag | Utilizacao de acidos bisfosfonicos para o tratamento de angiogenese |
| US6677320B2 (en) * | 2000-01-20 | 2004-01-13 | Hoffmann-La Roches Inc. | Parenteral bisphosphonate composition with improved local tolerance |
| ATE314862T1 (de) * | 2000-05-05 | 2006-02-15 | Hoffmann La Roche | Gelartige pharmazeutische zusammensetzung zur subcutanen anwendung enthaltend bisphosphonsäuren oder deren salze |
| HU228400B1 (en) * | 2000-06-20 | 2013-03-28 | Novartis Ag | The use of bisphosphonates for treatment of osteoporosis |
| GB0029111D0 (en) * | 2000-11-29 | 2001-01-10 | Novartis Ag | Organic compounds |
| JP2002332235A (ja) * | 2001-02-01 | 2002-11-22 | Riderway Corp | 骨疾患治療用液体医薬組成物 |
| ITMI20020908A1 (it) | 2002-04-29 | 2003-10-29 | Chemi Spa | Processo di preparazione di sodio alendronato |
| CN1939314A (zh) * | 2002-05-10 | 2007-04-04 | 弗·哈夫曼-拉罗切有限公司 | 用于治疗和预防骨质疏松症的二膦酸 |
| WO2003099992A2 (en) * | 2002-05-17 | 2003-12-04 | Wyeth | Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| SI1596870T2 (sl) * | 2002-12-20 | 2011-07-29 | Hoffmann La Roche | Formulacija z visokim odmerkom ibandronata |
| DE602004032577D1 (de) * | 2003-12-23 | 2011-06-16 | Alchymars S P A | Amorphe Form das Natriumsalzes der Ibandronsäure |
| WO2006002348A2 (en) * | 2004-06-23 | 2006-01-05 | Teva Pharmaceutical Industies Ltd. | Solid and crystalline ibandronic acid |
| HUE042316T2 (hu) | 2005-02-01 | 2019-06-28 | Atnahs Pharma Uk Ltd | Az Ibandronát A polimorf orvosi alkalmazása |
| WO2006081962A1 (en) | 2005-02-01 | 2006-08-10 | F.Hoffmann-La Roche Ag | Ibandronate polymorph b |
| WO2007074475A2 (en) | 2005-12-27 | 2007-07-05 | Natco Pharma Limited | Novel polymorphic forms of ibandronate |
-
2005
- 2005-08-23 DE DE202005021414U patent/DE202005021414U1/de not_active Expired - Lifetime
- 2005-08-23 PT PT05791142T patent/PT1713489E/pt unknown
- 2005-08-23 EP EP05791142A patent/EP1713489B1/en not_active Revoked
- 2005-08-23 KR KR1020077005922A patent/KR20070043043A/ko not_active Ceased
- 2005-08-23 CN CNA2005800285039A patent/CN101022812A/zh active Pending
- 2005-08-23 CA CA002576659A patent/CA2576659A1/en not_active Abandoned
- 2005-08-23 AT AT05791142T patent/ATE495747T1/de not_active IP Right Cessation
- 2005-08-23 ES ES05791142T patent/ES2358269T3/es not_active Expired - Lifetime
- 2005-08-23 JP JP2006536948A patent/JP4559431B2/ja not_active Expired - Lifetime
- 2005-08-23 KR KR1020097022363A patent/KR20090120011A/ko not_active Ceased
- 2005-08-23 DE DE602005025977T patent/DE602005025977D1/de not_active Expired - Lifetime
- 2005-08-23 PT PT08002626T patent/PT1930011E/pt unknown
- 2005-08-23 AT AT08002626T patent/ATE520406T1/de not_active IP Right Cessation
- 2005-08-23 WO PCT/US2005/030500 patent/WO2006024024A2/en not_active Ceased
- 2005-08-23 EP EP08002626A patent/EP1930011B1/en not_active Expired - Lifetime
-
2006
- 2006-12-22 US US11/644,568 patent/US7563918B2/en not_active Expired - Fee Related
-
2007
- 2007-02-13 IL IL181298A patent/IL181298A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007512237A5 (enExample) | ||
| JP2007302683A5 (enExample) | ||
| JP2011527299A5 (enExample) | ||
| JP2009235100A5 (enExample) | ||
| JP2014005302A5 (enExample) | ||
| JP2015145426A5 (enExample) | ||
| HRP20171175T1 (hr) | Novi triciklički spojevi | |
| JP2018024682A5 (enExample) | ||
| JP2023002516A5 (enExample) | ||
| FI2629097T1 (fi) | Nrf2-seulontatestejä ja niihin liittyviä menetelmiä ja koostumuksia | |
| HRP20140666T1 (hr) | Kristalni oblici derivata 2-tiazolil-4-kinolinil-oksi, snažnog hcv-inhibitora | |
| JP2013509429A5 (enExample) | ||
| JP2014523445A5 (enExample) | ||
| JP2010513478A5 (enExample) | ||
| HRP20181048T1 (hr) | Neuroaktivni 19-alkoksi-17-supstituirani steroidi, korisni u postupcima liječenja | |
| HRP20150584T1 (hr) | Soli i polimorfi tetraciklinskog spoja | |
| JP2011500621A5 (enExample) | ||
| HRP20130026T1 (hr) | Kristalni oblik posakonazola | |
| HRP20140004T1 (hr) | Novi spojevi 951: bifeniloksipropanska kiselina kao crth2 modulator i intermedijeri | |
| NZ592383A (en) | Pharmaceutical composition of a potent hcv inhibitor for oral administration | |
| JP2008518904A5 (enExample) | ||
| HRP20150062T1 (hr) | Farmaceutski pripravak koji sadrži optički aktivan spoj koji sadrži agonist receptora trombopoietina i njegov međuprodukt | |
| HRP20150184T1 (hr) | Makrocikliäśki spoj i postupci za njegovu proizvodnju | |
| HRP20151338T1 (hr) | [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-[7-fluoro-1-(2-metoksi-etil)-4trifluorometoksi-1h-indol-3-il]metanon kao inhibitor triptaze mastocita | |
| JP2008516004A5 (enExample) |